Bench to Bedside: Cell Therapy Development and Commercialization Roadmap

摘要

Over the past decade, the cell therapy field has matured into the next generation of medical technology. In both the United States and the European Union, physicians now have an option to write prescriptions for manufactured engineered cell therapeutics, as they routinely do for prescription medications. And the number of available commercial cell therapies is expected to grow. However, unlike traditional pharmaceuticals, engineered cell therapeutics require geographically dispersed networks of cellcollection, engineering, manufacture, distribution logistics, and treatment facilities, thus presenting a yet unseen set of challenges for those involved in cell therapy development and commercialization.